1. Home
  2. LCTX vs MBCN Comparison

LCTX vs MBCN Comparison

Compare LCTX & MBCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.63

Market Cap

407.7M

Sector

Health Care

ML Signal

HOLD

Logo Middlefield Banc Corp.

MBCN

Middlefield Banc Corp.

N/A

Current Price

$34.89

Market Cap

274.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
LCTX
MBCN
Founded
1990
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
407.7M
274.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LCTX
MBCN
Price
$1.63
$34.89
Analyst Decision
Strong Buy
Hold
Analyst Count
4
1
Target Price
$4.25
$35.00
AVG Volume (30 Days)
1.3M
17.4K
Earning Date
11-06-2025
01-22-2026
Dividend Yield
N/A
2.39%
EPS Growth
N/A
48.42
EPS
N/A
2.61
Revenue
$10,816,000.00
$75,400,000.00
Revenue This Year
$6.32
$19.98
Revenue Next Year
$124.49
$7.42
P/E Ratio
N/A
$13.47
Revenue Growth
24.05
16.60
52 Week Low
$0.37
$22.74
52 Week High
$2.09
$37.68

Technical Indicators

Market Signals
Indicator
LCTX
MBCN
Relative Strength Index (RSI) 42.32 46.08
Support Level $1.63 $35.18
Resistance Level $1.77 $36.09
Average True Range (ATR) 0.08 0.71
MACD -0.01 -0.33
Stochastic Oscillator 11.36 5.75

Price Performance

Historical Comparison
LCTX
MBCN

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

About MBCN Middlefield Banc Corp.

Middlefield Banc Corp is a bank holding company. It offers customers, banking services including checking, savings, negotiable order of withdrawal (NOW) accounts, money market accounts, time deposits, commercial loans, real estate loans, a variety of consumer loans, safe deposit facilities, and travelers' checks. It also provides online banking and bill payment services to individuals and online cash management services to business customers.

Share on Social Networks: